{
    "code": "02024549",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024549",
    "time": "2017-01-13 03:39:20",
    "許可證字號": "衛署藥輸字第024549號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/10\/16",
    "發證日期": "95\/10\/16",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202454900",
    "中文品名": "科比多格爾",
    "英文品名": "Clopidogrel Hydrogen Sulphate",
    "適應症": "降低近期發生中風、心肌梗塞或週邊動脈血管疾病的粥狀動脈硬化病人之粥狀動脈硬化事件的發生。",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "主成分略述": [
        ""
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620110H286  宇直泰貿易有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F200444100  HETERO DRUGS LIMITED, UNIT- I",
        "製造廠廠址": "SURVEY NO. 213, 214 &amp; 255, BONTHAPALLY VILLAGE, JINNARAM MANDAL, MEDAK DISTRICT, TELANGANA STATE, INDIA",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "29349990901 其他雜環化合物Other heterocyclic compounds",
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "Clopidogrel Hydrogen Sulphate-標籤-105-07-15.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024549&Seq=001&Type=8"
        }
    ]
}